3Barrett D,Liaw S T,de Lusignan S.Unravelling the tangled taxonomies of health informatics[J].Inform Prim Care,2014,21(3):152.
4Dargaville P A,Kamlin C O,De Paoli A G,et al.The OPTIMIST-A trial:evaluation of minimally-invasive surfactant therapy in preterm infants 25-28 weeks gestation[J].BMC Pediatr,2014,14(1):213.
5Kulkarni N B,Ganu M U,Godbole S G,et al.Effect of age and Blood Pressure on Surrogate Markers of Atherosclerosis in Patients with Type 2 Diabetes Mellitus[J].J Clin Diagn Res,2014,8(6):BC08.
6Strathmann F G,Schulte S,Goerl K,et al.Blood-based biomarkers for traumatic brain injury:evaluation of research approaches,available methods and potential utility from the clinician and clinical laboratory perspectives[J].Clin Biochem,2014,47(10/11):876.
7Hofmann P A.Critical path method:An important tool for coordinating clinical care[J].Jt Comm J Qual Improv,1993,19(7):235-246.
8Healy WL, Iorio R, Ko J, et al. Impact of cost reduction programs on short - term patient outcome and hospital cost of total knee arthroplasty[ J ]. J Bone Joint Surg Am, 2002,84 - A ( 3 ) : 348.
